Semax 30mg nasal spray by Hudson Science. 500mcg per actuation, high concentration nootropic and neuroprotective neuropeptide spray for extended research protocols. Lab tested, discreetly shipped across Canada. Intended for research purposes only.
Format30mg Nasal Spray
Concentration500mcg / Spray
Pack Size Selected: 5 Pack
Pay with Interac e-Transfer or Crypto
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. The same institution responsible for Selank with regulatory approval as a nootropic and neuroprotective agent in Russia and Ukraine. Hudson Science’s 30mg nasal spray delivers 500mcg per metered spray actuation; the highest total compound and per actuation concentration in CSD’s Semax nasal spray range, sitting substantially above the Hudson Science 5mg nasal spray at 50mcg per spray and providing a six fold increase in total compound supply suited to extended research programmes or higher concentration dose response evaluation.
The 30mg and 5mg Semax nasal spray presentations serve distinct research purposes within CSD’s Semax delivery range. The 5mg format at 50mcg per actuation provides granular low dose titration capability suited to initial compound evaluation, conservative dose response characterization, and protocols examining Semax’s BDNF and NGF neurotrophic upregulation at the lower end of the concentration spectrum. The 30mg format at 500mcg per actuation addresses extended protocol timelines requiring substantial compound supply from a single unit, higher concentration research examining Semax’s neuroprotective, cognitive enhancement, and dopaminergic pathway modulation at dose points beyond what the 5mg format can support, and comparative dose response studies spanning a broad concentration range within the same compound family.
The intranasal delivery route is the primary clinically referenced administration format for Semax; intranasal delivery has been the standard format studied in Russian medical research since the compound’s original development, with olfactory epithelium proximity providing potential direct CNS access via the olfactory nerve pathway to Semax’s hypothalamic and cortical neurotrophic targets. This CNS access advantage is particularly relevant for Semax’s BDNF and NGF upregulation mechanism. Neurotrophins that support neuronal survival, synaptic plasticity, and new neural connection formation in brain regions directly accessible through the olfactory nerve route, making intranasal delivery the most pharmacokinetically aligned format for Semax’s central neuroprotective research applications.
Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks Semax across three formats: this 30mg nasal spray, the 5mg nasal spray, and the Hudson Science 5mg lyophilized vial, alongside the closely related Selank across four formats, giving researchers complete Semax concentration, delivery route, and supply volume flexibility from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at 2–8°C away from direct light. Do not freeze. Keep upright. Intended for research purposes only.
Commonly researched alongside Selank and Pinealon in comparative nootropic and neuroprotective peptide studies. Browse CSD’s full peptide range for complete sourcing.
